Tchaikapharma

Tchaikapharma is a leading Bulgarian pharmaceutical company focused on the development, manufacturing, and marketing of high-quality generic medicinal products. Headquartered in Sofia, the company operates two state-of-the-art manufacturing facilities in Plovdiv and Varna, both of which are fully GMP-certified. Its extensive product portfolio covers critical therapeutic areas such as cardiology, neurology, gastroenterology, and diabetology. Tchaikapharma is publicly traded on the Bulgarian Stock Exchange and serves as a vital player in the healthcare sector of Southeast Europe. The company also engages in strategic partnerships with international pharmaceutical giants to bring innovative therapies to the regional market.